Guidelines as a Framework for Improved Outcomes in Ph+ ALL

Dr. Bijal Shah highlights the critical role of evidence-based guidelines, including NCCN recommendations, in standardizing care and enhancing outcomes for patients with Ph+ ALL.

Now Viewing

EP: 1.Guidelines as a Framework for Improved Outcomes in Ph+ ALL

EP: 2.Evolving Treatment Paradigms in Ph+ ALL

EP: 3.Expectations for Anticipated Guideline Updates: Addressing Key Gaps in Ph+ ALL Care

EP: 4.Looking Ahead: Ph+ ALL in 2025 and Beyond

• In your view, why are guidelines for managing Ph+ ALL important to improving patient care and outcomes?
• What role does the National Comprehensive Cancer Network (NCCN) play in shaping treatment practices for Ph+ ALL?

Related Videos

Related Content

Advertisement

June 16th 2025

Methotrexate Adds No Benefit to Adalimumab in Psoriasis Treatment, Study Suggests

Pearl Steinzor

Target trial emulation study finds no added effectiveness or persistence with combination therapy for plaque psoriasis.

December 23rd 2024

Five Years Later: Ongoing COVID-19 Challenges, Next Steps

Brooke McCormick

On this episode of Managed Care Cast, we speak with Jenny Han, MD, of Emory School of Medicine and Grady Hospital, about COVID-19, long COVID, and strategies for prevention and care.

June 14th 2025

A Look at Those With Durable Responses to Epcoritamab in LBCL

Mary Caffrey

A post-hoc analysis of EPCORE-NHL-1 was presented at ASCO.

December 17th 2024

Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi

Three abstracts presented at the 2024 American Society of Hematology annual meeting focused on patient preferences and treatment choices in blood cancers.

June 14th 2025

Hematology in Space: Understanding How Blood Behaves Differently in Orbit

Christina Mattina

Our knowledge of the effects of space and low gravity on blood cells, clotting, and anemia continues to expand, but further research is needed as commercial spaceflights are poised to grow in popularity.

June 13th 2025

Obesity Guidelines Differ for Adult, Pediatric Patients

Jared Kaltwasser

A new analysis of obesity guidelines suggests more evidence is needed to develop stronger guidelines for the transition period between childhood and adulthood.

Related Content

Advertisement

June 16th 2025

Methotrexate Adds No Benefit to Adalimumab in Psoriasis Treatment, Study Suggests

Pearl Steinzor

Target trial emulation study finds no added effectiveness or persistence with combination therapy for plaque psoriasis.

December 23rd 2024

Five Years Later: Ongoing COVID-19 Challenges, Next Steps

Brooke McCormick

On this episode of Managed Care Cast, we speak with Jenny Han, MD, of Emory School of Medicine and Grady Hospital, about COVID-19, long COVID, and strategies for prevention and care.

June 14th 2025

A Look at Those With Durable Responses to Epcoritamab in LBCL

Mary Caffrey

A post-hoc analysis of EPCORE-NHL-1 was presented at ASCO.

December 17th 2024

Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi

Three abstracts presented at the 2024 American Society of Hematology annual meeting focused on patient preferences and treatment choices in blood cancers.

June 14th 2025

Hematology in Space: Understanding How Blood Behaves Differently in Orbit

Christina Mattina

Our knowledge of the effects of space and low gravity on blood cells, clotting, and anemia continues to expand, but further research is needed as commercial spaceflights are poised to grow in popularity.

June 13th 2025

Obesity Guidelines Differ for Adult, Pediatric Patients

Jared Kaltwasser

A new analysis of obesity guidelines suggests more evidence is needed to develop stronger guidelines for the transition period between childhood and adulthood.